Healthcare Innovation

Healthcare Innovation

Healthcare innovation has been a mixed bag, and for the investor, embarrassingly faddish

In this review of ETFs, profiles are more diverse than their names suggest, with some funds putting emphasis on new fields of medical expertise centered on genomics and often still at the research stage, others on the more broadly defined biotechnology segment, and finally some on applied technology (IT) as new up-and-coming investor darling 

Under the guise of 'diversification', there appears to be uncertainty about the most promising trends and realistic assessment of revenue streams derived from discoveries (often still at clinical stage)

One arguably significant ETF - in terms of assets under management (AUM) -  set aside in this selection is ARK Invest Genomic Revolution because of the fund’s extreme volatility, reflecting its exclusive exposure to 21st century ambitions (or dreams)

Successful investment strategies in the health sector may temper the optimism of medical breakthroughs and of transformative IT applications with hard questions about the financial value added, as our forthcoming notes will discuss

Healthcare Innovation • Updated:

Name Ticker Exchange Category SubCategory Currency Cur.Price AUM Perf. Momentum Vol. Risk Contrib. MDD
ALPS Medical Breakthroughs SBIO NYSEARCA Health Care Research Advance USD 47.10 216 M 31.2% Sharp Down 35%   11% -27%
ETFMG Treatments Testing and Advancements ETF GERM NYSEARCA Health Care Diagnostics USD 35.21 - 40.0% Sharp Down 35%   9% -43%
Franklin Genomic Advancements ETF HELX BATS Health Care Research Advance USD 44.79 - 80.0% Neutral 33%   10% -26%
Global X Genomics & Biotechnology ETF GNOM NASDAQ Health Care Research Advance USD 22.36 - 60.5% Sharp Down 37%   12% -24%
Global X Telemedicine & Digital Health ETF EDOC NASDAQ Health Care Logistics & Services USD 19.74 - 26.8% Neutral 22%   6% -31%
Invesco Dynamic Biotechnology & Genome ETF PBE NYSEARCA Health Care Biotech USD 73.63 213 M 46.1% Neutral 30%   10% -17%
iShares Genomics Immunology and Healthcare ETF IDNA NYSEARCA Health Care Research Advance USD 44.93 - 54.9% Sharp Down 33%   11% -22%
Loncar Cancer Immunotherapy ETF CNCR NASDAQ Health Care Biotech USD 28.00 38 M 29.7% Weak Down 33%   10% -22%
Loncar China BioPharma ETF CHNA NASDAQ China Investable Market USD 37.09 - 52.1% Neutral 28%   6% -17%
ROBO Global® Healthcare Technology and Innovation ETF HTEC NYSEARCA Health Care Research Advance USD 45.53 - 77.6% Neutral 25%   8% -20%
Virtus LifeSci Biotech Products ETF BBP NYSEARCA Health Care Biotech USD 51.28 25 M 23.8% Weak Down 28%   8% -17%